Bilirubin—A Possible Prognostic Mortality Marker for Patients with ECLS

Extracorporeal life support (ECLS) is a promising therapeutic option for patients with refractory cardiogenic shock. However, as the mortality rate still remains high, there is a need for early outcome parameters reflecting therapy success or futility. Therefore, we investigated whether liver enzyme...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Clin Med
Autori principali: Bunte, Sebastian, Walz, Roland, Merkel, Julia, Torregroza, Carolin, Roth, Sebastian, Lurati Buse, Giovanna, Dalyanoglu, Hannan, Akhyari, Payam, Lichtenberg, Artur, Hollmann, Markus W., Aubin, Hug, Huhn, Ragnar
Natura: Artigo
Lingua:Inglês
Pubblicazione: MDPI 2020
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7356548/
https://ncbi.nlm.nih.gov/pubmed/32503278
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9061727
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi